fda compounding semaglutide Approval vs Compounded Alternatives The Risks of Compounded Semaglutide
Description
Weight regain risk varies, but sustainable routines and behaviour change usually play an important role in long-term maintenance
Following a 731 percent increase in utilization of the drug (up to more than 23,000 members utilizing GLP-1s for weight loss purposes) by 2024, the Board estimated the cost in 2024 to exceed $170 million and jump to more than $1 billion over the next six years
It originates from unrelated contexts (like muscle-building supplements) that do not apply to GLP-1 agonists
It enhances insulin secretion in response to meals, slows gastric emptying, and promotes satiety
